Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]

Tu.A.2095 - Tu.A.2100 Tuesday July 9, 1996 in that some licenrsed HIV antibody screening assays failed to detect some individuals infected with this strain. Most infections with HIV- I' group O strains have been reported among people fronm- Cameroonr, (aon and Nigeria, some of them living in Belgium, France, and Germany. Patients and methods Because a high proportion of patients attending our institution are immigr, ints, namely from West Africa, al sera tested for HIV were firstly analyzed using a mixed antigen HIV I plus HIV 2 IA, and repeatedly reactive specimens are further con firmed using both an HIVI vii lysate Western blot (VWB) and osynthetic peptide- based assay (Pept-LAV 1+2). In this form, HIV2 antibodies are more definitively excluded than excus vely using the recommended HIV I WB analysis. Given that mostly HIV - I roup (.) sera are negative on Pepti- LAV after being EiA reactive or cut off, the mentioned algonrtm provides us the opportunity to collect a group of that samples might be candidates for HIVI group O infection. Specimens selected by this serological critenra and additional sera from HIV I + subjects from West Africa (epideririgcol crteria) were analyzed using a new line immunoassay from Innogenetics (Ito LIA HIV type O) which can recognize antibodies specifi for HIV type O. Results: Since January 1993, 832 sera were found to be reactive by one HIV I/2 EIA.WB and Peptl LAV confirmed 665 of them ais HIVseropos. None of 23 samples firom HIV I + Africans yiel ded reactivity on the no-IA HIV type O. Howeve one sample reacted on this test after testing 77 set a which yieded reactive or cut-off absorbances on EIA, Indetermlnate WB patterns and negattve resu lts on PL.The sera conrresponded to a 34-year old wom born in Spain, which had a monogamous sexua relation for the ast 6 years with 35 -eor-oldir, lie, and previusly only spurd ialiy with two other persons, all of whom denied risk pract ces. Howe ver he curenrt couple had been on duty n EquatorialGuinea for 10 years (1983-1992), where he had had mutiple sex partners Besides, he had ti aveled several times to Cameroon.The husband was EIA-reactive aond showed posit-ity for HIVI on W and P-L. Iiowever ie orly ected against HIV group O d not r ant ed on the Inno-L tA HIV,group O. We uoed prewousl ides ibed nested primer pudrs fro the e region for differentiatron between group and O cvruses n to wpatients. Both yielded posictve results exclusely for HIV group. Moreover; seq, ence analysis of e ov and f renomic regions confirmed these results and allowed ui to cluster our cases into the ANT-70 lade nstead o the MVP B 180orVAU. Conclusion: The reported cases of HIV-I,roup 0 infection in two persons of Spanish ori gin rase the possibility of the spread of dcerent HIV I isolates wordwide. In addition, it reinforces the utility of periodic surveillance studies at the international level in order to adapt current screennp oserological tests to the evolvin HIV epidemic. Dr.Vincent Sorano. Service Infectious Diseases, ISC III, C/Rafrel Calvo 7, 2 A, 28010 -Madrid, Spain. Phone: (34 I) 3 140807. Fax: 7336614 Tu.A.2095 MOLECULAR INVESTIGATION OF HIV-1 VARIANTS IN UKRAINE Grebenjuk Vladslv A', Anoprienko O ' Marichec I*', Kavsan V'. Institute of Moecular Biolog and Genetics, Klev, Ukrine: Institute of Epidemiology & Infection Diseases, Kiev Ukraine. Objective: 1o determine the extent of HIV- strains heterogeneity in Ukraine. Methods: Blood samples were collected from four (n=-4) HIVI seropositive male residents of Ukraine.Two of them are presumed to be nfected through heterosexsual contact and other two through homosexual contact. Al indrAiduals were first tested to be HIV. I postie within last two years and are stil asymptomatic. DNA samples derived from peripheral blood mononuclear cells of these pat0ents were used as templates for nested polymerise chain reaction. The 0,58 kb fiagments of gagene encoding p17 - p24 portion of ga polyprotein and, I kb fragmoents of env,ene encodinggpl60 C2 C5 porton were amplified, cloned and serquenced Sequences of PCR products were aligned and phylogenetic neighbour-jorning trees eerated. Results: All obtair ned nucleotde sequences of portions of gag gene when compared to HIV I reference strains of different subtypes were clustered to subtype B.iThe same dstribution was found for env sequences. Both obtained env and gag sequences from two homosexually inlected patients were most closely related.This i i a good correlation with the suggestion that they were infected by each other. Conclusion: Thus, we found that HIVI strains derived f-om four Ukrainian residents belonp to subtype B, which is widespread in Europe and also in Russia. Existence of any other -HIVI subtypes in Ukrainian population require further investigations. VA Grebenjuk 50 Zabolotnogo Street. Kiev 252627, Ukraine Telephone: +380-44 -2663498 Fax:+380-44 266398 emal: kavsan( oimbig.kiev.ua Tu.A.2096 CHARACTERIZATION OF HIV-I QUASISPECIES REPERTOIRE IN INFANTS AND CHILDREN BY HETERODUPLEX GEL SHIFT ANALYSIS Essajee, Shaffiq M. Pollack H, Rochford GC. Oransky I, Kr-asinski K. Borkowsky W. Department of Pediatric Infectiotus Dsease, New York University Medical C renter New York, USA Objective: Most individuals infected with HIV harbor not one but several different genotypes df the cirus. Stud es i-lult h ie estbishod a rorielaon between greater viral dicorspty rid looper eurvah ihilr o V3 does not icst for te pedi tic population Du m s to hiarate innz oe th on of DIV quasspecies in dnts an d children and roetoepatters of dre no v with ucif e outcom e and parameters of rioune function. Methods: Too subeconts 6 slow progressors nd 4 rspd propessos), were selected frorn cohent of DIV infected chidrer followed pr ospectivelp si000 b i th.Threy had boon seen it monthly intercils when cl ncal ecillustronr were performrod. aod DIV-I nncwtro ant body (IVAb) production from o troed per phersl hlood lymphocytes winscmeasured. Nested DIV DNA PCR win performertd or sequent.l specimens of peripherl ifblood mononucloar cells to aroplify the V3-VS ropion of the onc poee Saroples wore seror-qurnified by end-point dilutin o staindardize0copy n urobe Usrngp radio-labelied probe gonerasled irene the initial specor en closest to Ibirth, honoroduplox gol sIt Bnlsos (GSA) was performed no yielda piclopiraphic record fo eah child of V3-VS Bonertic vaten rover time. Results: Ir '4 of the rnfir Itsomore thant ooe quasispOes was identlfied it hirth.The 4 rap d propriessors showed no ecdence Iorn fus pc en ecolton duriop the period of th e study B8-1 Bmton) By conrt, t of too p} slor pi0Bo5rs5 shtowed the appoararoo of new quasispecies by 4-6 months In addition, none of the rapid progressors made IVAb during the first year of life, whereas in all but one of the sow progressors, IVAb production was detected at the time of or prior to changes in quasispecies repertoire. There was no association between the presence of more quasspecies it birth and either more rapid d esese progression or more rapid viral evolut ion. Conclusion: More than one quasispecies is often transm itted to verticaly infected nf nts. For slow progressors, changes in the population of quasispeces occurred in most cases by the fi st 6 months of life, and appeared to be associated with evidence of a strong nfant immune response. Infants who progressed rapidlyfailed to show any changes i, t-e quasspecies repertoire and also failed to produce signficant amounts ofin- vitro ant;body in this relatively small study w e have shown that heteroduplex analysis of viral diversity has some predictive value in determining clinical0 outcome.The ssociation between ncreased viral diversity and ncreased IVAb product on lends weight to the hypothesis that immune pressure plays a role in driving viral evolution. Further study is needed to shed Ight on the significance of these findings. Shaffiq M1 Essajee, 415 East Ninth Street 91 NewYork, NY 10009 USATel: (212) 562 361 2 Fax: (2 12) 263 7806 email:essajs0lO!gcrc.med.rnyu.edu Tu.A.2098 NONINFECTIOUS HIV- I -LIKE PARTICLES WITH HETEROLOGOUS IMMUNOLOGICAL MARKERS AS NOVEL AIDS VACCINE CANDIDATES Yao Fei- LongCao S X, Cates G, JtmesO C), Chong Persson R, Matthews T, Kle n MP, Roinsk B. Connaught Laboratories Ltd, Ontan oiCaiida. Objective: To eng ineer anti genicall s-marked HIV ike prtIcles whi ch permi t mmunol oical dislin ctr between vaccination and H IV-I nfecti or. Methods: An nduoble, humosa n metalloth onein -bas eeof pr-esoruce r n sbe f I poducpn HI- like partices with chimeric gp 120MN/,p1LAI envelope lycoprote!rs wis mut- i genized to en neer a vect orcapable of prsoducing vorus-Ike partices 0 contain- aeterologous transmembrian re anchor sequence fu sed to the carboxy-termnus of gpp120oMN. othis end, a DNA sequence encoding a 57 me peptide contaninp 22 amino acids fom the human influenza virus HA2 protein was inserted into specific locus wthin the HIV oenvelopeg ene by gene assembly-aided mutagenes, (GAAM). Results: Monkey kidneyVero cells transfected with this vector were shown to produce DIVI-like prtces devoid of gp41 and contoining the modified gpl20 protein. Immunization owith these particles induci ed HIV- type-specific net cra zins antibod ies as well as antibodies recognizingr the heterologous angenic marker peptide. Conclusions: These studies demonstrate the lasibn' i ity of producing noni nfectious HI - I -ke paricles wttho pl20 envelope glycopinoteins anchored to the viralorane surace via heteroloous antigenic peptide fragments. Since those particles doo nt contain the HIV-I immunodominant region which is present within the tn s enrbrane glycoproten,mmunization with these HIVIlike antigens should allow a 0lewr distinction between vaccnation and live virus nfection. F-LYao, 1755 Steeles Ave.West. North York ON M2R 3T4 Telephone (4 6) 667-3391 Fax: (4 1 6) 667 2740 Tu.A.2099 MONOCLONAL ANTIBODIES AGAINST HIV- I p17 CROSS-REACT WITH ENV V3 LOOR Ota, Akemi, Watanabe M, ShangJ, Nakanish M, Leda S. Osaka Universt Csaka, Japan Objective: We found antibodies in serum samples of a HIV-1 carrier that cross-reacted with envV3 loop and p17 peptides of HIV-I. Among monoclonal antbodies (mAbs) against p17, some cross-reacted with envV3 oop.To confir rthis phenomenon, we examined newly obtained mAbs against p17 for their cross-reactlvty with env V3 loop. Method: MAbs aainst p 17 were obtained by immuni zin a pepti de, P30 52 (covenrng ami no acid position between 30th and 52nd), of p 17 n Balb/c mice. Cross reactvty and affinity constants were examined by ELISA in IBIAcore system. Results: Among ISMAbs newly obtained, 7 were IgM type and 8 were IgG type. ELISA tests using Covalsin k plates (Nun c) revealed that 14 of these rAbn s cross-reacted with an envV3 loop peptide. Affinity constants determined with BIAcore biosensor were between 1.4 x 10 and 7.6 x 107 (I/M'1). Indirect fluorescent antibody staining revealed that 8 mAbs reacted wth rhe cell surface of MT4 cells infected with JMH-I strain of HIV.Fou mAbs of gM type showed neutralizing activity and 4 of I1M type suppressed multiplication of the JM1 strain. Conclusion: MAbs against p 17 of HIV- Icross-reacted with an env V3 loop peptde. Some of them reacted with cel surface antigens of MT-4 cels infected with HIV I and showed suppressive effect on HIV I multiplication. A.Ota, 3-1 Yamada-oka, Suita city, Osaka. 565 Japan Tel:06-879-8300 Fax:06-875- 1170 ema l:otadobiken.osaka-u.ac.jp Tu.A.2100 TCA3 AND INTERLEUKIN- 12 AS CYTOKINE ADJUVANTS ON CANDIDATE HIV- I DNA VACCINE Tesus Tadash Hamaia K. Ishir N. ADr Yan K, Saraid S. fwa rho d Fu clnoa J, Ododa K. Yokohanta City UnroersitY hoohans sapin Objective: To detemino whetherTCA3 and inter eudmLp 2 expression pami dn have adf oct1 stiites or DIV-i speciic nmed 'ed immu nity p CMIw iuced 'p Ocr nddateO DIVI DNA vacione. Methods: TCA3 or IL- 12 expre sson plisnid was cornocuilotd roth DIVI 1118 p160 expresion planmid (hereafter DNA va50iref into cionse gastrocremtic rouncles.Two woods after inooculat on. Delayed typo hypersenicvty (DTD roan assayed by osn 0 foolpad sine opg nosponse.Three woods after inoculsIon, rytoocT lymphocyte CTb) acitr~teo wis 0000u ated Op using standard 5Co~reloise is syTmo and four- weeds ifter rnoculation, the DIVspecifho antibody Inter nO rorounizod nero mrs evalcaned by using enzynto lided rmmunosor Lent asay Results: The DIVI specific CMI (DTD an d C TL rctortes roa errhinced by 000nocula100 of eich cytodrne oxpressron plasrord rod DNA orccno comparood itL vco no anne.TIhe DIV-i specific honoram immunity mas rather ouppressed whenr rho vacorne mms rootled with TCA3 exprossnor plasroidI 281

/ 516
Pages

Actions

file_download Download Options Download this page PDF - Pages 241-290 Image - Page 281 Plain Text - Page 281

About this Item

Title
Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]
Author
International AIDS Society
Canvas
Page 281
Publication
1996
Subject terms
abstracts (summaries)
Item type:
abstracts (summaries)

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0110.046
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0110.046/291

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0110.046

Cite this Item

Full citation
"Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0110.046. University of Michigan Library Digital Collections. Accessed May 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel